Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Pre-mRNA processing factor 40 homolog B (PRPF40B) is a human protein that acts as a splicing factor, associating with the U1 small nuclear ribonucleoprotein (snRNP) complex and interacting directly with SF1 and U2AF(65) proteins to facilitate the accurate assembly of spliceosomal machineries at pre-mRNA splice sites[1][2]. PRPF40B helps modulate alternative splicing, especially repressing exon inclusion for weak splice sites and regulating genes critical for cell survival and apoptosis, such as Fas[1][2]. Loss of PRPF40B disrupts normal alternative splicing patterns, induces apoptosis, and alters expression of genes involved in iron metabolism, hypoxia, and cholesterol biosynthesis—implicated in certain cancers, including acute myeloid leukemia and myelodysplastic syndrome[2][3]. PRPF40B does not contain an RNA recognition motif but functions through interactions mediated by WW and FF domains[2]. There are currently no drugs or therapeutic biologics developed to target PRPF40B directly.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Pre-mRNA processing factor 40 homolog B (PRPF40B).